Results 111 to 120 of about 2,944 (157)

Qualitative analysis of genomic mutations and antibiotic susceptibility testing of Pseudomonas aeruginosa isolates from chronic lung infections. [PDF]

PLoS One
Fluit AC, Bayjanov JR, Aguilar MD, Cantón R, Gilpin DF, Tunney MM, Ekkelenkamp MB.   +6 more
europepmc   +1 more source

A global view of morphogenetic peptidoglycan synthases across the domain Bacteria. [PDF]

Microlife
García-Del Portillo F, López-Escarpa D, Peñalver M, Castanheira S.   +3 more
europepmc   +1 more source

Ceftazidime-avibactam resistance evolution in <i>Pseudomonas aeruginosa</i> and implications for cross-resistance to other novel β-lactams. [PDF]

Antimicrob Agents Chemother
Dorazio AJ, Kline EG, Squires KM, Shah S, Van Tyne D, Wu JY, Pogue JM, Shields RK.   +7 more
europepmc   +1 more source

Unravelling the triad of penicillin-binding proteins, β-lactamase activity, and mRNA dynamics in Pseudomonas aeruginosa AmpC induction. [PDF]

J Antimicrob Chemother
Montaner M, Montes M, Alajarin F, López-Argüello S, Oliver A, Moya B.   +5 more
europepmc   +1 more source

Targeting mycobacterial transpeptidases: evaluating the roles of Ldt and PBP inhibition in suppressing <i>Mycobacterium smegmatis</i>. [PDF]

Antimicrob Agents Chemother
de Munnik M, Calvopiña K, Rabe P, Schofield CJ.   +3 more
europepmc   +1 more source

Antimicrobial resistance characteristics and associated molecular mechanisms of clinically isolated <i>Haemophilus influenzae</i> from the lower respiratory tract in Chongqing, China. [PDF]

Front Cell Infect Microbiol
Huang Q, Xiang R, Wu Y, Zhang W, Xie W, Liu Z, Quan N, Gao Y, Xiong Z, He L, Fu J, Mu D, Wang Y.   +12 more
europepmc   +1 more source

<i>In vivo</i> selection of CMY-219 conferring resistance to ceftazidime-avibactam in an OXA-484-producing <i>E. coli</i> ST410. [PDF]

Antimicrob Agents Chemother
Jousset AB, Girlich D, Oueslati S, Birer A, Delaval A, Guyot C, Rezzoug I, Emeraud C, Naas T, Bonnin RA, Dortet L.   +10 more
europepmc   +1 more source

Sporadic cefiderocol resistance in Escherichia coli from the United Arab Emirates involves multifactorial mechanisms reversible by novel beta-lactamase inhibitors. [PDF]

Sci Rep
Al-Marzooq F, Ahli H, Aldhaheri R, Aleissaee O, Alzaabi A, Alsaadi A, Almansoori H, Ghazawi A, Daoud L, Ahmad A, Collyns T.   +10 more
europepmc   +1 more source

Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions. [PDF]

Antibiotics (Basel)
Miftode IL, Radu VD, Jigoranu RA, Leca DA, Prepeliuc CS, Pasare MA, Miftode RS, Grigoriu MG, Parângă TG, Miftode EG.   +9 more
europepmc   +1 more source

Evolution of beta-lactam resistance causes fitness reductions and several cases of collateral sensitivities in the human pathogen <i>Haemophilus influenzae</i>. [PDF]

Antimicrob Agents Chemother
Petersen S, Diricks M, Utpatel C, Schulenburg H, Merker M.   +4 more
europepmc   +1 more source